SEM
Select Medical Holdings Corp
$16.51
-0.02 (-0.12%)
At close · Jun 30
Market Cap
$2.05B
Shares
124,016,800
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$16.51
Open$16.53
Day$16.51–16.56
52W$11.49–16.92
Avg vol 30d2.5M
Short int1.2M · 0.9% float · 1.0d
Short vol13%
Last earningsApr 30, 2026
DataJan 2020–Jun 2026
Filing10-Q · Apr 30
Up next
Next earnings call
Jul 30, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Low
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+9%
above
Price vs 50-day avg
+0%
above
RSI (14)
46
neutral
MACD trend
Negative
52-week position
92%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+8%
trailing
YTD return
+12%
this year
Relative strength
0%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $17 › 200d $15 — 50d above 200d
Institutional flow
Distributing
8 of 276 funds reported for Jun 30 · net -2.0K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.93% of float · ▼ -52.1% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
276 holders — mid 3-yr range
Squeeze score
36
low risk · 0–100
Fundamentals
Revenue growth
+5%
Y/Y
EPS growth
−30%
Y/Y
Valuation
P/E 15.4
below peers
Buyback
$303.2M
remaining
Balance sheet
$3.4B
net debt
Quant / Vol
risk profile
Volatility
31%
annualized · 1-yr
Max drawdown
−23%
past year
ATR
0.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Apr 30, 2026
fiscal year 2026
Revenue
Maintained
$5.6B – $5.8B
prior FY $5.45B
midpoint +4.5% Y/Y
Fully diluted earnings per share
Maintained
$1.22 – $1.32
prior FY $1.16
midpoint +9.5% Y/Y
full year 2026
Adjusted EBITDA
Maintained
$520M – $540M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+9%
Bullish
Price vs 50-day avg
+0%
Bullish
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
92%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $17 › 200d $15 — 50d above 200d
Institutional flow
Distributing
8 of 276 funds reported for Jun 30 · net -2.0K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.93% of float · ▼ -52.1% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
276 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $11
Now $17 · 92%
52-wk high $17
vs 200-day avg +9%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings per common share non-GAAP | $0.36 | first quarter ended March 31, 2026 | — |
| Adjusted EBITDA non-GAAP | $141.6M | first quarter ended March 31, 2026 | — |
|
|
|||
| critical illness recovery hospital segment Adjusted EBITDA non-GAAP | $73.4M | first quarter ended March 31, 2026 | — |
| critical illness recovery hospital segment Adjusted EBITDA margin non-GAAP | 11.5% | first quarter ended March 31, 2026 | — |
| critical illness recovery hospitals operated | 103 | as of March 31, 2026 | — |
| outpatient rehabilitation clinics operated | 1,912 | as of March 31, 2026 | — |
| rehabilitation hospitals operated | 41 | as of March 31, 2026 | — |
| states with operations | 38 | as of March 31, 2026 | — |
| availability on revolving loans | $443.5M | Q1 2026 call | — |
| beds added across three newly opened inpatient rehabilitation hospitals | 166 | so far this year 2026 call | — |
| critical illness recovery hospital division adjusted EBITDA non-GAAP | $73.4M | Q1 2026 call | — |
| critical illness recovery hospital division adjusted EBITDA margin non-GAAP | 11.5% | Q1 2026 call | — |
| critical illness recovery hospital division admissions growth | 1% | Q1 2026 call | — |
| days sales outstanding | 60 | Q1 2026 call | — |
| inpatient rehabilitation hospital division adjusted EBITDA non-GAAP | $81.1M | Q1 2026 call | — |
| inpatient rehabilitation hospital division adjusted EBITDA margin non-GAAP | 23% | Q1 2026 call | — |
| inpatient rehabilitation hospital division average daily census growth | 12% | Q1 2026 call | — |
| inpatient rehabilitation hospital division occupancy | 83% | Q1 2026 call | — |
| inpatient rehabilitation hospital division same-store occupancy | 87% | Q1 2026 call | — |
| net leverage | 3.75 | Q1 2026 call | — |
| outpatient rehabilitation division adjusted EBITDA non-GAAP | $22M | Q1 2026 call | — |
| outpatient rehabilitation division adjusted EBITDA margin non-GAAP | 6.8% | Q1 2026 call | — |
| outpatient rehabilitation division net revenue per visit | $102 | Q1 2026 call | — |
| outpatient rehabilitation division patient visits growth | 4% | Q1 2026 call | — |
| Critical illness recovery hospitals | 104 | As of December 31, 2025 | — |
| Outpatient rehabilitation clinics | 1,917 | As of December 31, 2025 | — |
| Rehabilitation hospitals | 38 | As of December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SEM
this stock
Select Medical Holdings Corp
|
$2.05B | +11.6% | +5.1% | 15.4 | 0.9% |
|
HCA
HCA Healthcare, Inc.
|
$90.20B | -12.8% | +7.1% | 14.0 | 2.4% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$27.44B | -15.0% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$17.59B | +2.8% | -2.3% | 10.6 | 4.3% |
|
DVA
Davita Inc.
|
$14.95B | +104.9% | +6.5% | 21.7 | 7.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SEM | -0.3% | +0.0% | +7.8% | +0.1% | +11.7% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | -2.1% | +1.6% | -0.1% | +1.3% | +2.1% |
Capital returns
Latest dividend
$0.0625
/ share · ex May 14, 2026
Paid (TTM)
$0.25
/ share · 4 payouts
Dividend yield (TTM, derived)
1.51%
Buyback program
· as of Dec 31, 2025
Authorized
$1.00B
Spent (derived)
$696.80M
Remaining
$303.20M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.